Educating Women about Benign Breast Disease

Adair L. (1985). Lumpy breasts. Consultant, 25(11), 55–56.

Bartow S. Pathak D. Black W. Key C. , & Teaf S. (1987). Prevalence of benign, atypical and malignant breast lesions in populations at different risk for breast cancer. Cancer, 60, 2751–2760.

Bates B. (1983). A guide to physical examination. Philadelphia: J.B. Lippincott.

Birnbaum S. , & Westheimer O. (1980, December). Breast lumps: Cysts and benign. Mothers Manual, 10–12.

Davis J. (1988). Fibrocystic disease. Early Detection, 11(2), 1.

Drukker B. , & deMendonca W. (1987). Fibrocystic change and fibrocystic disease of the breast. Obstetrics and Gynecology Clinics of North America, 154(1), 161–179.

Dupont W. , & Page D. (1985). Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine, 312, 146–151.

Fentiman I. , & Powles T. (1987). Tamoxifen and benign breast problems. Lancet, 8567, 1070–1071.

Fogel C. , & Woods N. (1981). Health care of women, a nursing perspective. St. Louis: C.V. Mosby Co.

Goldenberg I.S. (1982, March 15), When breasts are fibrocystic. Patient Care, 103–147.

Haagensen C. (1986). Diseases of the breast (3rd ed.), Philadelphia: W.B. Saunders.

Hane N. (1989, May). The breast through the lifespan and benign disorders. Paper presented at BSE II Update. Norman, Oklahoma.

Heyden S. Fodor J. (1986). Coffee consumption and fibrocystic breasts: An unlikely association. The Canadian Journal of Surgery, 29, 208–211.

Lauwers J. , & Woessner C. (1983). Counselling the nursing mother. Wayne, NJ: Avery Publishing Group.

Lawrence R. (1980). Breast-feeding, a guide for the medical profession. St. Louis: C.V. Mosby Co.

Levinson W. , & Dunn P. (1986) Nonassociation of caffeine and fibrocystic breast disease. Archives of Internal Medicine, 146, 1773–1775.

London R. S. Sundaram G. S. , & Goldstein P. J. (1982). Medical management of mammary dysplasia. Obstetrics and Gynecology, 59, 519–523.

Love S. (1984). Lumpy breasts. Medical Forum. 10, 3–5.

Minton J. Foecking M. Webster D. , & Matthews R. (1979). Caffeine, cyclic nucleotides, and breast disease. Surgery, 86(1), 105–109.

Osuch J. (1987). Benign lesions of the breast other than fibrocystic change. Obstetrics and Gynecology Clinics of North America, 14, 703–710.

Parazzini F. La Vecchia C. Riundi R. Pampallona S. Regallo M. , & Scarmi A (1986). Methylxanthine, alcohol-free diet and fibrocystic breast disease: A factorial clinical trial. Surgery, 99, 576–581.

Pilnik S. , & Leis H. (1978). Nipple discharge. In Gallager H. S. Leis H. P. , & Snyderman R. K. (Eds.) The Breast. St. Louis: C.V. Mosby Co.

Potchen E. , & Sierra A. (1987). The detection and cure of breast cancer. Obstetrics and Gynecology Clinics of North America, 14, 667–684.

Russell L. (1989). Caffeine restriction as initial treatment for breast pain. Nurse Practitioner, 14, 36–40.

Scott E. (1986). Fibrocystic breast disease. Archivum Fratrum Praedicatorum, 36, 119–126.

Townsend C. (1980). Breast lumps. Clinical Symposia, 32(2), 3–30.

Vorherr V. (1986). Fibrocystic breast disease: Pathophysiology, pathomorphology, clinical picture, and management. American Journal of Obstetrics and Gynecology, 154(1), 161–179.